Multi-Site Study of COVID-19 Patients Utilizing Fluidigm Mass Cytometry Technology and Maxpar Direct Immune Profiling Assay

  • Adeeb Rahman

Press/Media

Period29 Jun 2020

Media coverage

1

Media coverage

  • TitleMulti-Site Study of COVID-19 Patients Utilizing Fluidigm Mass Cytometry Technology and Maxpar Direct Immune Profiling Assay
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date29/06/20
    PersonsAdeeb Rahman
View all 1
View less